Pharma Deals Review, Vol 2006, No 75 (2006)

Font Size:  Small  Medium  Large

Telbivudine

Business Review Editor

Abstract


Telbivudine (originally LdT, short for β-2’-deoxy-L-thymidine) is under joint development by Idenix Pharmaceuticals (formerly Novirio Pharmaceuticals) and Novartis Pharma to treat chronic HBV infection.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.